Levocarnitine Use Is Associated With Improvement in Sarcopenia in Patients With Liver Cirrhosis

Although the effect of levocarnitine (L‐carnitine) on hyperammonemia has been reported in patients with liver cirrhosis (LC), its effect on sarcopenia remains to be elucidated. We assessed the effects of L‐carnitine on sarcopenia in patients with LC. We retrospectively evaluated 52 patients with LC...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Hepatol Commun
Egile Nagusiak: Hiramatsu, Akira, Aikata, Hiroshi, Uchikawa, Shinsuke, Ohya, Kazuki, Kodama, Kenichiro, Nishida, Yuno, Daijo, Kana, Osawa, Mitsutaka, Teraoka, Yuji, Honda, Fumi, Inagaki, Yuki, Morio, Kei, Morio, Reona, Fujino, Hatsue, Nakahara, Takashi, Murakami, Eisuke, Yamauchi, Masami, Kawaoka, Tomokazu, Miki, Daiki, Tsuge, Masataka, Imamura, Michio, Tanaka, Junko, Chayama, Kazuaki
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: John Wiley and Sons Inc. 2019
Gaiak:
Brief Reports
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6396356/
https://ncbi.nlm.nih.gov/pubmed/30859147
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/hep4.1309
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak